PSB-KK1415
![]() | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C24H23ClN6O2 |
| Molar mass | 462.94 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
PSB-KK1415 is an experimental drug that acts as a potent and selective agonist for the cannabinoid-like NAGly receptor, also known as GPR18. It has potential applications in studying the immune system and development of cancer.[1]
References
- ^ Mahardhika AB, Załuski M, Schoeder CT, Boshta NM, Schabikowski J, Perri F, et al. (June 2024). "Potent, Selective Agonists for the Cannabinoid-like Orphan G Protein-Coupled Receptor GPR18: A Promising Drug Target for Cancer and Immunity". Journal of Medicinal Chemistry. 67 (12): 9896–9926. doi:10.1021/acs.jmedchem.3c02423. PMID 38885438.
